
The ultimate guidebook on everything you need to know about reducing hospital readmissions-the most common risk factors, the reimbursement issues, and how real-world hospitals are solving the problem.
Keith Loria is a contributing writer to Medical Economics.

The ultimate guidebook on everything you need to know about reducing hospital readmissions-the most common risk factors, the reimbursement issues, and how real-world hospitals are solving the problem.

The ultimate guidebook on everything you need to know about reducing hospital readmissions-the most common risk factors, the reimbursement issues, and how real-world hospitals are solving the problem.

Although he dreamed of becoming an architect, John Baackes now has designs on creating a better future for managed care.

How healthcare leadership is changing due to market trends, and the new skills healthcare executives need to thrive.

A look at what payers are-or should be-focusing on in terms of their strategy for getting customers.

Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes

A look at recent developments in treatment and the cost implications of various autoimmune diseases.

With more than four decades in healthcare, Joe Swedish has started a private equity firm aimed at improving healthcare.

The future of executive compensation at managed care organizations will be based on incentives.

These are the important policies to watch out for in 2019.

Joan Budden has created a culture at Priority Health, the No. 2 health insurer in Michigan, that encourages and rewards innovative thinking.

Healthcare experts weigh in on what we can expect in 2019 and beyond.

Innovation doesn’t happen by accident-here’s how healthcare organizations around the country are bringing their operations and technologies into the future.

As a third-generation physician, Marc Harrison, has become an influential leader.

The food people eat and the toxins they are exposed to on a daily basis are two of the biggest contributors to the likelihood of developing an autoimmune disease, according to many health experts.

Protein produced by common gut bacteria may trigger the onset of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and ulcerative colitis.

Moving up the corporate ladder can be frustrating-here’s are six tips from industry experts

Although it’s still unknown what the mechanisms are that contribute to MS-related fatigue, certain dietary approaches can help treat it.

A Yale University study has revealing findings about how diet impacts patients with lupus.

Growing up in in Limerick, Ireland, Michael J. Dowling admits his family situation was a little complicated-his mother was deaf and his father suffered from heart disease and arthritis. Read more about his early life and what led to his rise in healthcare.

A new Chinese study highlights a potential cell therapy strategy for autoimmune diseases in a clinic setting.

A new study theorizes organs affected by autoimmune disease suppress immune cells using methods similar to those used by cancer cells to evade detection.

As drug costs continue to increase at an unsustainable rate, some hospitals are finding new solutions.

Results of 20-year cohort study reveal that women with history of this serious medical illness are more vulnerable to lupus.

New research has revealed that this approach could aid in the treatment of autoimmune diseases, as well as help with diabetes, chronic pain and numerous other conditions.

A new Swedish study examined gender differences in rheumatism and other autoimmune diseases. Here are the surprising findings.

A new study has surprising findings about traumatic or stressful life events and the link to developing an autoimmune disease.

A South Korean study may contribute to the improvement of personalized therapeutic outcomes for rheumatoid arthritis by expanding the scope of molecular imaging.

A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.

Successful hospitals share the strategies they have used to reduce readmissions.